Wondfo Biotech – Leading POCT Company Specialize in the IVD Industry

Home
About us

About Wondfo

Wondfo Commitment

Global Sustainability

Wondfo Heritage

Wondfo FAQs
Products

The first developed technology platform with various application scenarios, including infectious disease, fertility, DOA, etc.

50+ kinds of reagents and five high-performance devices, focusing on detecting cardiovascular disease, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and others.

Single-dose Chemiluminescense Immunoassay Platform

Wondfo optical blood coagulation analyzer is the first one in the world that can test PT, APTT, TT, FIB, and ACT simultaneously.

Our Blood Gas Analyzer BGA-102 can produce the result in 30s. Its advantages of portability, easy operation, durability, and high performance make it ideal for clinics, laboratories, and hospitals.

Wondfo Dry Chemistry Analyzer can test 16 items and provide the result within 2 minutes, ideal for the detection of cardiac markers, kidney function, liver function, pancreatitis, etc.

Ready-to-use lyophilized RT-PCR Reagent；
Gold Standard for COVID-19 Diagnosis

Wondfo PA-3600 IHC Staining System

Colloidal Gold Platform

Immunofluorescence Platform

Chemiluminescence Platform

Coagulation Platform

Blood Gas Platform

Dry Biochemical Platform

Molecular Diagnostics Platform

Pathology Platform
Solutions

Advanced rapid diagnostic test with WHO prequalification for infectious disease

The Future Intelligent Medical Assistant to Healthcare

Fight against the pandemic through continuous innovation

International Public Health Solutions

1㎡ POCT Lab

COVID-19 Total Solution
Careers
Resource Center

Video

Product Brochure

COVID-19 Information

Wondfo Academy
News & Press
Contact Us

Contact Us

Event Registration

Global

中文

English (N.A.)

English (Global/Glob.)

Русский

Español

Our Technologies

Colloidal Gold Platform

- The most developed technology platform.The first developed technology platform
- Easy to Use-require no equipment
- Comprehensive Application Scenarios-acute infectious disease, DOA, etc.
- Wondfo 2019-nCov Antibody Test kit-first batch approved in China

Learn More +

Immunofluorescence Platform

The platform includes 50+ kinds of reagents and five high-performance devices, focusing on detecting cardiovascular disease, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and others.
The number of our Finecare Meter series installed in all levels of medical institutions is the largest in China. Our Finecare Meter series also have the broadest test menu.

Learn More +

Chemiluminescence Platform

1. Reliable calibration and quality control system
2. Carry-over prevention
3. Maintenance-free, no liquid path inside
4. No extra consumables
5. Compact instrument design
6. Simple operation
7. No hidden cost
8. 600 days MTBF

Learn More +

Coagulation Platform

The platform includes Semi-Automatic Blood Coagulation Analyzer and Optical Blood Coagulation. Our optical blood coagulation analyzer can test PT, APTT, TT, FIB, and ACT simultaneously, the first of its kind in the world.

Learn More +

Blood Gas Platform

Wondfo Blood Gas Analyzer BGA-102 can deliver results of a patient’s oxygenation levels, pH, and electrolyte balance on the spot in the 30s.
It is ideal for many point -of-care settings, such as emergency departments, ICU, and laboratories.

Learn More +

Dry Biochemical Platform

Wondfo Dry Chemistry Analyzer can test 16 items and provide the result within 2 minutes, ideal for the detection of cardiac markers, kidney function, liver function, pancreatitis, etc.

Features:
- The most comprehensive biochemical tests
- Enhanced enzymes stability

Learn More +

Molecular Diagnostics Platform

· Integrated diagnostic solution
· Full-automatic
· 1 Test Cassette = 1 Micro PCR Lab

Learn More +

Pathology Platform

Wondfo PA-3600 IHC Staining System includes the high-performance device, ancillary reagents, and consumables, designed to provide automated, flexible, easy-to-use, and accurate immunohistochemically staining solutions.

Learn More +

Solutions

1㎡ POCT Lab

COVID-19 Total Solution

About us

Domestic POCT Industry Leader

We have been committed to safeguarding health and improving lives with better products, services, and solutions since founded in 1992 in Guangzhou. Today, with more than 3000 employees, we'll continue to innovate and shape the future of POCT and healthcare.

3000 +

Employees
800 +

Researchers
150 +

Countries / Regions
20 +

Subsidiaries

Learn More+

This website uses cookies. By continuing to browse or by clicking “Accept”, you agree to our use of cookies to enhance your experience.

Choose your location